Rivus Pharmaceuticals
ID: 7682646Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity.
2
Funding Rounds
$167.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Al*** Cu******** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Rivus Pharmaceuticals has raised a total of $167m in funding over 2 rounds.
Key Insights:
- Rivus Pharmaceuticals - Series B round, September 2022: $132m
- Rivus Pharmaceuticals Series A round, July 2021: $35m
Industries
Rivus Pharmaceuticals is active in the following industries: